Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have earned a consensus recommendation of “Buy” from the six research firms that are currently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $12.13.
A number of brokerages have recently issued reports on BIOX. Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Roth Mkm dropped their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Lake Street Capital decreased their price objective on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Finally, Oppenheimer lowered their price objective on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st.
Check Out Our Latest Report on Bioceres Crop Solutions
Institutional Trading of Bioceres Crop Solutions
Bioceres Crop Solutions Stock Down 4.8 %
BIOX stock opened at $6.13 on Monday. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The company has a market cap of $385.27 million, a PE ratio of 306.65 and a beta of 0.49. The business’s 50-day simple moving average is $7.24 and its 200 day simple moving average is $9.52.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The firm had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same period in the previous year, the business posted ($0.07) EPS. On average, research analysts anticipate that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Further Reading
- Five stocks we like better than Bioceres Crop Solutions
- Buy P&G Now, Before It Sets A New All-Time High
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Most Volatile Stocks, What Investors Need to Know
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Where to Find Earnings Call Transcripts
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.